| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $500.9M | -0.6% |
| Cost of Revenue | $277.7M | -1.5% |
| Gross Profit | $223.2M | +0.5% |
| R&D Expense | $41.3M | +2.9% |
| SG&A Expense | $64.3M | -2.2% |
| Operating Income | $19.9M | -29.3% |
| Pre-tax Income | $24.7M | -11.7% |
| Income Tax | $8.1M | -24.7% |
| Net Income | $16.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.1M | +6.3% |
| Short-term Investments | $14.0M | -26.3% |
| Accounts Receivable | $66.5M | -8.7% |
| Inventory | $12.3M | -9.9% |
| Current Assets | $194.9M | -2.9% |
| Total Assets | $743.5M | -3.7% |
| Current Liabilities | $53.3M | +7.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77.8M | +6.2% |
| Capital Expenditures | $9.2M | -67.4% |
| Investing Cash Flow | -$13.6M | -198.3% |
| Financing Cash Flow | -$58.5M | -39.9% |
| Free Cash Flow | $68.7M | +52.0% |
| -3.6% |
| EPS (Basic) | $0.66 | +0.0% |
| EPS (Diluted) | $0.66 | +0.0% |
| Total Liabilities |
| $73.4M |
| -4.8% |
| Stockholders' Equity | $670.2M | -3.6% |